HOME >> MEDICINE >> NEWS
Case study: cross-cultural bioethics training program helps fight African 'brain drain'

Baltimore When African professionals migrate to the United States or Europe, its often called brain drain. In the world of research ethics, at least one training program is causing the opposite effect. Now entering its eighth year of operation, the Johns Hopkins Fogarty African Research Ethics Training Program is the subject of a sweeping new case study published in the July 2007 issue of Academic Medicine. For the first time, the case study reveals some potent lessons in what it takes to deliver a successful, cross-cultural ethics training program.

We initially sought to increase the critical mass of African individuals professionally trained in ethics, said Nancy Kass, ScD, deputy director for public health at the Johns Hopkins Berman Institute of Bioethics and the programs director. But it also turns out that our trainees are making institutional changes to policies, drafting new guidelines, and generally raising awareness of the need to support research ethics. And some trainees are not just doing these things in their home countries, but throughout the continent.

In a region devastated by the HIV/AIDS epidemic, the trainees provide encouraging evidence of success in the global effort to work collaboratively with African professionals to develop their own ethics-based research methods. After studying in Baltimore for six months under the supervision of a mentor with similar research interests, trainees return to Africa to begin a six-month practicum on the topic of their choice related to the ethics of research. One trainee returned to Zimbabwe, eager to share his newfound expertise at more than 30 workshops in surrounding regions. Another returned to the Democratic Republic of Congo and established two Institutional Review Boards (IRBs). Another trainee helped design international guidelines for HVI vaccines.

During the practicum, trainees implement all they have learned in the classroom, said Adnan Hyder, MD, MPH, PhD, the
'"/>

Contact: Ed Bodensiek
ebodensiek@jhu.edu
410-516-8523
Johns Hopkins University
2-Jul-2007


Page: 1 2 3

Related medicine news :

1. HealthGrades study: Bariatric surgery patients have fewer complications at high-volume hospitals
2. New study: Pycnogenol reduces heart failure
3. New study: Pine bark significantly reduces endometriosis
4. FSU study: Can prunes reverse bone loss after menopause?
5. New study: Preterm birth causes one-third of all infant deaths
6. FSU study: Abortion notification, consent laws reduce risky teen sex
7. National study: Patients poorly prepared for end-of-life decisions
8. UCLA/VA study: Many patients not receiving follow-up tests after positive screening for colon cancer
9. U-M study: Program to boost elderly flu vaccination could save lives
10. Loyola study: Telemetry captures stroke patients cardiac problems
11. Mayo Clinic study: People with heart failure at significant increase for death from stroke

Post Your Comments:
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Alternatives, ... permits some patients to quit using drugs while allowing ... Adi Jaffe, the founders of Alternatives, believe that abstinence-only ... before they enter treatment and that this approach hurts ... million people in the United States need treatment for ...
(Date:6/19/2013)... St. Louis, MO (PRWEB) June 19, 2013 ... solutions organization, partnered with ARAMARK Healthcare Technologies to ... equipment management plan with savings of more than ... repair and maintenance service expenditures. , “Driving economies ... the top medical equipment management challenges facing multi-site ...
(Date:6/19/2013)... a world-leading provider of scientific, technical and medical ... of the National Osteoporosis Guideline Group (NOGG) Update ... postmenopausal women and older men in the journal ... Maturitas , the original guidelines have been ... an additional focus on the management of glucocorticoid-induced ...
(Date:6/19/2013)... Mass. (PRWEB) June 19, 2013 ... security solutions, today announced that Imprivata OneSign ® ... KLAS® 2013 Mid-Term Performance Review: Software & Services report ... KLAS laud Imprivata on the superior performance of its ... support, and they indicate that Imprivata is integral to ...
(Date:6/19/2013)... According to Transparency Market Research “Endoscopy devices Market ... Forecast, 2011 – 2017,” the global endoscopy devices market ... and is expected to reach USD 10.8 billion by ... to 2017. Flexible endoscopes formed the largest category in ... for the year 2011. , Related Report : Medical ...
Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3
(Date:6/19/2013)... , June 19, 2013 NeuroDerm, ... study in volunteers, and preliminary results from a phase ... presented at the 2013 International Congress of Parkinson,s Disease ... drug formula under development for continuous administration through a ... plasma concentrations. ND0612 has been shown in ...
(Date:6/19/2013)... 19, 2013   Life Technologies Corporation ... agreement granting Suzhou Ribo Life Sciences (Ribo) the ... in China using Life,s ... siRNA molecules in combination with Invivofectamine® Rx to ... diseases with high unmet medical need in the ...
(Date:6/19/2013)... , 19. Juni 2013 ... mit der Entwicklung von SCS microRESIST™, ... in der Beschichtung mit Parylene gelungen ... von biokompatiblem Parylene mit antimikrobiellen Eigenschaften ... schädlicher Mikroorganismen auf beschichteten medizinischen Geräten. ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
Cached News: